Skip to main content
. 2021 Feb 16;12:628977. doi: 10.3389/fpsyg.2021.628977

TABLE 3.

Predictors of treatment outcome based on interactions between time and the outcome measures.

Predictor BDI total score CORE-OM total score CORE-OM well-being CORE-OM problems/symptoms CORE-OM life functioning CORE-OM risk/harm






df1 df2 F p R2 Obs. pw df1 df2 F p R2 Obs. pw df1 df2 F p R2 Obs. pw df1 df2 F p R2 Obs. pw df1 df2 F p R2 Obs. pw df1 df2 F p R2 Obs. pw
Sociodemographic variables
Age 3 48.19 0.13 0.944 0.19 0.08 3 45.66 0.22 0.884 0.15 0.10 3 45.75 1.01 0.395 0.22 0.21 3 45.66 0.02 0.995 0.13 0.02 3 47.40 1.42 0.250 0.13 0.36 3 49.42 0.91 0.442 0.09 0.35
Gender 3 48.29 1.04 0.383 0.20 0.00 3 45.75 1.17 0.331 0.16 0.00 3 45.57 1.21 0.318 0.21 0.00 3 46.02 1.15 0.340 0.14 0.00 3 47.23 1.37 0.264 0.14 0.00 3 49.47 1.64 0.191 0.10 0.00
Clinical variables
Psychotropic medication 3 48.89 1.61 0.199 0.20 0.52 3 46.71 1.71 0.179 0.15 0.53 3 46.68 0.59 0.623 0.21 0.22 3 46.87 1.48 0.231 0.13 0.45 3 47.92 1.38 0.262 0.12 0.46 3 50.19 1.23 0.307 0.09 0.31
Comorbidity 3 48.00 1.38 0.259 0.20 0.00 3 45.89 0.65 0.588 0.15 0.00 3 45.47 0.91 0.443 0.22 0.00 3 46.06 0.87 0.462 0.13 0.00 3 47.30 0.49 0.691 0.13 0.00 3 48.65 0.26 0.856 0.11 0.00
Type of symptoms (externalizing) 3 48.85 0.18 0.907 0.19 0.00 3 46.31 0.03 0.993 0.16 0.00 3 45.93 0.09 0.965 0.22 0.00 3 46.47 0.29 0.836 0.14 0.00 3 47.95 0.41 0.747 0.13 0.00 3 50.07 0.14 0.933 0.08 0.00
C-GAS baseline 3 45.08 0.69 0.560 0.19 0.00 3 44.06 1.24 0.306 0.16 0.00 3 44.07 1.28 0.293 0.23 0.00 3 43.78 0.73 0.541 0.15 0.00 3 44.39 3.21 0.032 0.14 0.00 3 44.61 0.33 0.800 0.10 0.00
BDI total score baseline 2 45.03 0.79 0.459 0.71 0.00 2 43.67 0.23 0.795 0.52 0.00 2 44.49 0.54 0.589 0.46 0.00 2 43.55 0.15 0.860 0.47 0.00 2 44.24 0.14 0.867 0.45 0.00 2 44.20 1.49 0.237 0.40 0.00
CORE-OM total score baseline 2 45.07 0.78 0.463 0.62 0.00 2 43.75 0.24 0.786 0.58 0.00 2 44.80 0.75 0.479 0.52 0.00 2 43.71 0.16 0.855 0.55 0.00 2 44.04 0.06 0.941 0.52 0.00 2 43.82 1.52 0.230 0.39 0.00
CORE-OM well-being baseline 2 44.52 0.59 0.558 0.55 0.00 2 43.14 0.39 0.683 0.51 0.00 2 44.25 0.92 0.407 0.55 0.00 2 43.44 0.52 0.597 0.44 0.00 2 43.12 0.27 0.768 0.45 0.00 2 43.24 1.01 0.373 0.33 0.00
CORE-OM problems/symptoms baseline 2 45.14 0.77 0.468 0.56 0.00 2 43.97 0.18 0.834 0.58 0.00 2 44.80 0.66 0.521 0.49 0.00 2 43.76 0.08 0.922 0.61 0.00 2 44.47 0.12 0.884 0.46 0.00 2 43.62 1.33 0.274 0.34 0.00
CORE-OM life functioning baseline 2 44.94 1.15 0.326 0.48 0.00 2 43.70 0.50 0.610 0.45 0.00 2 44.49 1.05 0.358 0.42 0.00 2 43.83 0.21 0.815 0.36 0.00 2 44.22 0.38 0.685 0.49 0.00 2 43.94 1.11 0.338 0.26 0.00
CORE-OM risk/harm baseline 2 45.88 0.45 0.639 0.59 0.00 2 44.10 0.87 0.427 0.45 0.00 2 44.58 0.43 0.656 0.41 0.00 2 44.08 0.70 0.500 0.39 0.00 2 44.43 1.52 0.230 0.36 0.00 2 44.06 1.63 0.207 0.57 0.00
Treatment-related variables
Form of treatment 3 48.58 0.14 0.935 0.19 0.04 3 45.99 0.17 0.917 0.16 0.05 3 45.69 0.42 0.741 0.21 0.12 3 46.14 0.53 0.661 0.14 0.12 3 47.32 0.45 0.721 0.13 0.15 3 48.99 0.30 0.826 0.09 0.10
Frequency of treatment 3 48.70 3.07 0.036* 0.20 0.58 3 46.37 3.57 0.021* 0.17 0.74 3 45.41 2.74 0.054* 0.23 0.69 3 47.21 4.13 0.011* 0.15 0.78 3 47.97 3.10 0.035* 0.14 0.49 3 48.72 0.67 0.577 0.09 0.24
Psychological variables
Locus of control 3 46.69 0.28 0.837 0.18 0.00 3 43.75 0.98 0.410 0.15 0.00 3 43.92 1.08 0.366 0.21 0.00 3 43.91 0.50 0.683 0.14 0.00 3 45.45 1.64 0.194 0.12 0.00 3 48.72 0.16 0.921 0.09 0.00

*Significant at p < 0.05 level.

C-GAS, Children’s Global Assessment Scale; BDI, Beck Depression Inventory; CORE-OM, Clinical Outcomes in Routine Evaluation – Outcome Measure; Obs.pw, Observed power.